December 31, 2019

In This Issue
Dr. John Yindra to Step Down from MMA Committee for Physician Quality
Licensing Boards Propose Rule Changes for Opioid Use Disorder Treatment, Pain Prescribing
Human Genome Editing is Here. How Should It Be Governed?
Five Big Medical Court Cases that Made a Difference in 2019
Agreement Reached On FY 2020 Federal Funding and Extender Package
This Week's Public Health Updates from the AMA
Vaccine Vote Update: Healthcare Advocates File Citizens' Guide Statements
Latest ACA Ruling: What it Means Now For Doctors, Patients
Opioid Related Webinars Offer CME Credit
Resources From The Alzheimer's Association
MMA Legislative Calls Will Begin Tuesday, January 14th
Maine Legislature's List of Bill Titles for 2020 Session: Initial Approval List
Upcoming Specialty Society Meetings
8-Hour Free Live Course for Buprenorphine Waiver Training @MMC - January 27th
MMA partners with the Maine Suicide Prevention Program and the Maine CDC/Sweetser to offer training for clinicians.
10th Annual Maine Patient Safety Academy - March 30, 2020
Orthopedic Surgeon Opportunity in Beautiful New England
Northern Light Sebasticook Valley Hospital seeks a BC/BE General Surgeon
Family Medicine Physician
Family Medicine Opportunity in Beautiful Western Maine
BC/BE Family Medicine or Internal Medicine Physician
Opportunities at the VA for Volunteer Physicians
Volunteer Opportunity with Partners for World Health - Portland, ME

Search Back Issues



Follow Us:
Licensing Boards Propose Rule Changes for Opioid Use Disorder Treatment, Pain Prescribing

The Boards of Medicine, Osteopathic Medicine, and Nursing have proposed rules and rule changes to govern the use of medication assisted treatment in opioid use disorder (Chapter 12) and the prescribing of controlled substances for the treatment of acute and chronic pain (Chapter 21). The public comment period deadline is Friday, January 17, 2020 at 4:30 p.m.

Proposed Chapter 12, to govern treatment of opioid use disorder with medications such as buprenorphine, includes definitions, qualifications for those who seek to provide such treatment, and specific, detailed standards of practice for providers of Office-based Opioid Treatment (OBOT). It may be found here.

Chapter 21, governing the use of controlled substances in the treatment of acute and chronic pain, has been in effect since March of 2018. The new proposals cover several modifications of the rule with which any clinician who prescribes controlled substances for pain must be familiar. Those modifications include new exclusions for custodial care and hospice care and a recodification of the statutory exemptions in rule form. Notably, no changes have been made in the requirement that all clinicians licensed by the Board of Licensure in Medicine take 3 hours of CME in opioid prescribing regardless of whether they prescribe opioids or are authorized to do so by virtue of having a DEA number. The new form of Chapter 21, with proposed changes noted, may be found here.

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©